Skip to main content

icatibant

Generic: ICATIBANT ACETATE·Brand: FIRAZYR, Firazyr, ICATIBANT ACETATE, Sajazir

icatibant: 2 clinical trials tracked.

icatibant evidence translation

What we can confirm

2 tracked trials

No verified listed company relationship

What it means

AI will separate confirmed drug evidence from unknown company context.

What to watch

Watch trial status, endpoints, and the next source-backed update.
BioSniper AIPage evidence connected

Prepared research question

What is verified about icatibant, and what remains unknown?

Run cited research

Traceable citations · Unknowns marked

Clinical Trial Registry Records (2)

Prevention of Intradialytic Hypotension by Inhibiting Bradykinin B2 Receptor A Randomized, Double-blind, Placebo-controlled, Cross Over Explorative Study

NCT05834777Registry updated 2026-04-15·Phase 3
Recruiting

Primary endpoint: Blood pressure during hemodialysis

InterventionalRandomizedquadruple26 targetStarted 2023-12Completion 2026-111 site · United StatesVanderbilt University Medical Center

Specified Drug Use Surveillance of FIRAZYR Subcutaneous Injection 30mg Syringe for Pediatric Subjects With Hereditary Angioedema (All-Case Investigation)

NCT05509569Registry updated 2026-08-07
Completed

Primary endpoint: Number of Participants who Experience at Least One Treatment-Emergent Adverse Events (TEAE)

Observational32 enrolledStarted 2022-08Completion 2026-071 site · JapanTakeda